These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8693177)

  • 1. [A new generation of oral contraceptives and venous thromboembolic diseases: unexpected results!].
    Scarabin PY
    Rev Epidemiol Sante Publique; 1996 Apr; 44(2):188-9. PubMed ID: 8693177
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risk of thromboembolism and oral contraceptives].
    Lê MG
    Contracept Fertil Sex; 1996 May; 24(5):378-83. PubMed ID: 8704816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do third-generation oral contraceptives (OCs) increase the risk of venous thrombosis?
    Sapp AV; Lindbloom EJ
    J Fam Pract; 2001 Oct; 50(10):893. PubMed ID: 11674894
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism.
    Andersen BS; Olsen J; Nielsen GL; Steffensen FH; Sørensen HT; Baech J; Gregersen H
    Thromb Haemost; 1998 Jan; 79(1):28-31. PubMed ID: 9459317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives and venous thromboembolism.
    Paul C
    N Z Med J; 1996 Nov; 109(1033):413-5. PubMed ID: 8941290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 and antiphospholipid antibodies in women with contraceptive-related thromboembolic disease.
    Salobir B; Sabovic M
    Obstet Gynecol; 2004 Sep; 104(3):564-70. PubMed ID: 15339770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of thromboembolic side effects of oral contraceptives: methodologic recommendations].
    Póka R; Balogh I; Ajzner E; Nagy IG
    Orv Hetil; 1998 Apr; 139(14):815-8. PubMed ID: 9569728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptives and venous thromboembolism.
    Skegg D
    N Z Med J; 2000 Sep; 113(1117):385. PubMed ID: 11050907
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral contraceptives and thrombotic disease: risk of venous thromboembolism.
    Helmerhorst FM; Bloemenkamp KW; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 1997 Jul; 78(1):327-33. PubMed ID: 9198174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estrogens and cardiovascular diseases: should current guidelines be changed?].
    Beller F; Theiss W
    Zentralbl Gynakol; 1994; 116(8):441-8. PubMed ID: 7941812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraception was not associated with venous thromboembolic disease in recent study.
    Farmer RD; Todd JC; MacRae KD; Williams TJ; Lewis MA
    BMJ; 1998 Apr; 316(7137):1090-1. PubMed ID: 9552920
    [No Abstract]   [Full Text] [Related]  

  • 14. Thromboembolic disease and oral contraceptives.
    Can Med Assoc J; 1967 Aug; 97(6):302-3. PubMed ID: 6029252
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
    Rekers H; Norpoth T; Michaels MA
    Eur J Contracept Reprod Health Care; 1996; 1(1):21-30. PubMed ID: 9678134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives, thromboembolic disease, and hypertension: a review.
    Ferguson A
    J Med Assoc State Ala; 1977 Sep; 47(3):49-55. PubMed ID: 903728
    [No Abstract]   [Full Text] [Related]  

  • 17. Thromboembolism and oral contraceptives.
    Seigel DG
    Obstet Gynecol; 1971 Sep; 38(3):478-80. PubMed ID: 5094330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores.
    Eng PM; Seeger JD; Loughlin J; Clifford CR; Mentor S; Walker AM
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):297-305. PubMed ID: 18215000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are oral contraceptives safe?
    Coyle TF
    Aust Fam Physician; 1998 Jul; 27(7):578. PubMed ID: 9679374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.